SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: P. Ramamoorthy who wrote (175)8/8/1996 11:32:00 AM
From: Patrick Tang   of 849
 
Hi Ram: Technically, I am not too bullish about NMPS. Why? Its relatively strengh is deteriorating (while DJIA is up 250 points, it is still struggling to stay above its 200-DMA). Fundamentally, I am shock to discover that they actually spent $184,000 to depress their stock price (PPO). No wonder when their stupidity were reported yesterday, investors greeted them with a fury of selling. Mr. Chubb, you portfolio is thinnner, not chubbier, and you know you deserve it.

Your statement "... a sound technology with unique and cost effective product will general market interest..." is true logically and I agree with you 100%. However, without aggressive PR work, who in this planet will know about this? My mother-in-laws's great great grandson certainly doesn't know nuclear proteins. Look at it objectively, it has been exactly 1 month since the FDA approval and there are no coverage in major publications about this stunning technology. This alone will testify the ineptness of Chubb's PR effort.

In contrast, behold the ingenious stroke of PR expertise in VIAS for this week alone:

1. Convinced the editors of Fortune to publish a bullish article for the company (See reply #157, suggestion #2)

2. Convinced the editors of Business Week to publish a bullish report for the sector (See reply #157, suggestion #2)

3. Made rosy earning/sales forecast in teleconference with analysts (See reply #157, suggestion #9)

As a direct result of this aggressive PR feat, VIAS blast off and zoom up 18 points in FIVE trading days. That's PR work, Mr. Chubb. Are you still paying for Trahan's trash? I predict Trahan will be trashed. Soon.

For all NMPS investors: you should help youself by calling Mr. Chubb to suggest the followings:

1. Improve his PR work (See reply #157)

2. Send out FREE samples of the NMP-22 kits to all urologists in this planet (This is how money should be spent, not in the misfired PPO)

And finally, this breath-taking suggestion that ends all suggestions:

Direct his R/D folks to take on a revolutionary project: to invent a condom for detecting cervical cancer using the NMP technology. If CNBC shows this steaming diagnostic procedure on TV, NMPS will rocket to the moon. If Hollywood gets a hold of this technology procedure, NMPS will become a blockbuster. And if the League of Woman Voters endorsd this device, well, Mr. Chubb, you should be the next presidential candidate.

Best wishes from a mad monk (They don't call me MAD for nothing)

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext